AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
EFFICACY OF COMBINATION THERAPY WITH TRANDOLAPRIL AND VERAPAMIL-SR INPRIMARY HYPERTENSION - A 4X4-TRIAL DESIGN
Authors: DEQUATTRO V LEE DP MESSERLI F ALAGONA P ANGELO J HERKENDER C APPLEGATE W FOWLER N BENZ JR BOYDEN T PAMATER R CUTLER N LU ZW DOHERTY JE BRANDT D FELICETTA JV JOHNSON J LEFOR N GLASSER S HAWKINS C GOLDSTEIN R CARLSON K COOPER W GRAY JM HORWITZ L CLEGG L IVANHOE RJ WALKER P JAIN A MCMAHON FG VARGAS R GOTZKOWSKY S KAIHLANEN PM RUFF D ZUNKER R LEVINE J MCGUIRE R MASSIE B AMMON S MILLER W LUCKASEN G COLLINS F NEWMAN BG NOBLE R PASTER R COULTHARD D GEHIN B PLESKOW W PETERSON J PUNZI H RIESS J WALKER K VENKATA C RAM S REEVES R HALL J INOUE S JACQUES P SAVRAN S HESS T COWAN B SERFER HM SHAW D SILBERMAN H ROSEN J SCHAFFHAUSEN L MILANES M GABLES C SINGH B RABANAL P SNYDER F SOLER J STEIN W OSHRAIN C BUDD J ABBOTT R STRAUSS M ALSTADT K CARTER P WEBER M WEIR M MUELLER C URICK A WOLFSON PO DUNLAP S WIPPLE D BOHLNER N WOOD B MCGURREN N
Citation: V. Dequattro et al., EFFICACY OF COMBINATION THERAPY WITH TRANDOLAPRIL AND VERAPAMIL-SR INPRIMARY HYPERTENSION - A 4X4-TRIAL DESIGN, Clinical and experimental hypertension, 19(3), 1997, pp. 373-387
VALACICLOVIR VERSUS ACYCLOVIR IN THE TREATMENT OF FIRST-EPISODE GENITAL HERPES INFECTION - RESULTS OF AN INTERNATIONAL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL
Authors: FIFE KH BARBARASH RA RUDOLPH T DEGREGORIO B ROTH R CAMERON WB STEVENS S TYRING S LAPPIN M YOCKEY C HANSON M LONG B SNYDER F RAFFANTI S NELSON M TIPTON N BRITTON T COLLINS R GONTERO E GEIL J WRIGHT B DAVIDBAJAR K HANDSFIELD H GRIFFITH S DAVIS R LALONDE J WRIGHT L MCCRACKEN C WADDELL R PATEL R MINNS G BRIEFER C CHILD D KELSEY J WOOLLEY P SNOW R GARLAND S CURLESS E THATCHER S GUILL M HAVLICHEK D GOH B LUZZI G WOOD P REZA L STABLER C KATZ D GRANT D CAMPBELL J SEDLACEK T VANAMERONGEN D CHEETHAM D WESP J BINGHAM J DIX L CROOKS RJ
Citation: Kh. Fife et al., VALACICLOVIR VERSUS ACYCLOVIR IN THE TREATMENT OF FIRST-EPISODE GENITAL HERPES INFECTION - RESULTS OF AN INTERNATIONAL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL, Sexually transmitted diseases, 24(8), 1997, pp. 481-486
TRANDOLAPRIL AND VERAPAMIL SLOW-RELEASE IN THE TREATMENT OF HYPERTENSION - A DOSE-RESPONSE ASSESSMENT WITH THE USE OF A MULTIFACTORIAL TRIAL DESIGN
Authors: LEVINE JH APPLEGATE WB ALAGONA P ANGELO J HERKENDER C FOWLER N BENZ JR BOYDEN T PAMATER R CUTLER N DEQUATTRO V LU ZW DOHERTY JE BRANDT D FELICETTA JV JOHNSON J LEFOR N HAYDEN CT GLASSER S HAWKINS C GOLDSTEIN R CARLSON K COOPER W GRAY JM HORWITZ L CLEGG L IVANHOE RJ WALKER P JAIN A MCMAHON G VARGAS R GOTZKOWSKY S KAIHLANEN M RUFF D ZUNKER R MCGUIRE R MASSIE B AMMON S MILLER W LUCKASEN G NEWMAN BG NOBLE R PASTER R COULTHARD D GEHIN B PLESKOW W PETERSON J PUNZI H RIESS J WALKER K RAM CVS REEVES R HALL J INOUE S JACQUES P SAVRAN S HESS T COWAN B SERFER HM SHAW D SILBERMAN H ROSEN J SCHAFFHAUSEN L MILANES M SINGH B RABANAL P SNYDER F SOLER J STEIN W OSHRAIN C BUDD J ABBOTT R STRAUSS M ALSTADT K CARTER P WEBER M WEIR M MUELLER C WOLFSON PO DUNLAP S WIPPLE D BOHLNER N WOOD B MCGURREN N
Citation: Jh. Levine et al., TRANDOLAPRIL AND VERAPAMIL SLOW-RELEASE IN THE TREATMENT OF HYPERTENSION - A DOSE-RESPONSE ASSESSMENT WITH THE USE OF A MULTIFACTORIAL TRIAL DESIGN, Current therapeutic research, 58(6), 1997, pp. 361-374
CDP-CHOLINE-ALKYLACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE CATALYZES THE FINAL STEP IN THE DE-NOVO SYNTHESIS OF PLATELET-ACTIVATING-FACTOR
Authors: SNYDER F
Citation: F. Snyder, CDP-CHOLINE-ALKYLACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE CATALYZES THE FINAL STEP IN THE DE-NOVO SYNTHESIS OF PLATELET-ACTIVATING-FACTOR, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1348(1-2), 1997, pp. 111-116
IMMUNE-COMPLEX DISEASE CONSISTENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS IN A PATIENT WITH LYSINURIC PROTEIN INTOLERANCE
Authors: PARSONS H SNYDER F BOWEN T KLASSEN J PINTO A
Citation: H. Parsons et al., IMMUNE-COMPLEX DISEASE CONSISTENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS IN A PATIENT WITH LYSINURIC PROTEIN INTOLERANCE, Journal of inherited metabolic disease, 19(5), 1996, pp. 627-634
BIOSYNTHESIS OF N-ACETYLSPHINGOSINE BY PLATELET-ACTIVATING-FACTOR - SPHINGOSINE COA-INDEPENDENT TRANSACETYLASE IN HL-60 CELLS
Authors: LEE TC OU MC SHINOZAKI K MALONE B SNYDER F
Citation: Tc. Lee et al., BIOSYNTHESIS OF N-ACETYLSPHINGOSINE BY PLATELET-ACTIVATING-FACTOR - SPHINGOSINE COA-INDEPENDENT TRANSACETYLASE IN HL-60 CELLS, The Journal of biological chemistry, 271(1), 1996, pp. 209-217
ALTERED PLATELET-ACTIVATING-FACTOR LEVELS AND ACETYLHYDROLASE ACTIVITIES ARE ASSOCIATED WITH INCREASING SEVERITY OF BRONCHOPULMONARY DYSPLASIA
Authors: GAYLORD MS SMITH ZL LORCH V BLANK ML SNYDER F
Citation: Ms. Gaylord et al., ALTERED PLATELET-ACTIVATING-FACTOR LEVELS AND ACETYLHYDROLASE ACTIVITIES ARE ASSOCIATED WITH INCREASING SEVERITY OF BRONCHOPULMONARY DYSPLASIA, The American journal of the medical sciences, 312(4), 1996, pp. 149-154
EFFICACY AND SAFETY OF A 7-DAY, TRANSDERMAL ESTRADIOL DRUG-DELIVERY SYSTEM - COMPARISON WITH CONJUGATED ESTROGENS AND PLACEBO
Authors: GORDON SF THOMPSON KA RUOFF GE IMIG JR LANE PJ SCHWENKER CE WILSON P WILKINS L FORD C SHARP P SNYDER F COCHRAN J ROSS P KLETZKY O SUH B CABUS E NOTELOWITZ M THOMPSON C BREEN M BAYNE B MCQUARRIE HG BILANZICH S HEINE W KESSLER R STAFL J SOUSTEBY B FIELD CS HERRMANN B ADAMS R MOORE D FRIEDENSEN H FLANDER T MAXYMIV G HARRIS J VAUGHN C SHOUPE D NUNEZ V FERRARO LA FERRARO N JONES CA LEWIS J MINARD W HAYES C PARKER G RANKIN V GRIFFIN R GRUBBS A BABB P HOFF J PATANE J LYNN SC WHITE S PETERSON CM HEISTERMAN J WILKERSON G BULLOCK P GOLDBLATT D BAKER JM MADER N KUK D MERRITT M DAVIES E MERRILL LK SCREWS B PATEL M TUFTS C REYNOLDS C KENNEY R BURTON MC STEVENS C ELLINWOOD LE JOHNSON J NIELSEN JW DWIGHT R ORR JW ORR P CHANG CC BROUGH M MCRAE MA WINTERS M SMUCKER J ELCHINGER M BLOUNT CW CROMARTIE V COLLINS H COLLINS M PROSCH G ROOKIS L SHEVACH A FATIGATI V BRESSMAN P DIAL T COHEN M NANCE V MATILA P WALL E BYRNE B COLBERG C OKO F LAROSA J KENT L MILLER DJ MARTIN K BROWN A DIETIKER F GINSBERG D BREISH B STAUDT M HUNTER R RAU S DONAHUE PA KVAM DC HAWKINSON RW KANNIAINEN CM LAGUS JP CROWLEY JK BURNETT BL KETELSEN R HARRISON LI REYNOLDS SJ ELLMAN H WILTSHIRE JL HEMINGWAY LR
Citation: Sf. Gordon et al., EFFICACY AND SAFETY OF A 7-DAY, TRANSDERMAL ESTRADIOL DRUG-DELIVERY SYSTEM - COMPARISON WITH CONJUGATED ESTROGENS AND PLACEBO, International journal of fertility and menopausal studies, 40(3), 1995, pp. 126-134
PHOSPHOLIPID TRANSACYLATION AND THE FORMATION OF LYSO-PAF, THE PRECURSOR OF PLATELET-ACTIVATING-FACTOR (PAF)
Authors: SNYDER F SMITH ZL FITZGERALD V BLANK ML
Citation: F. Snyder et al., PHOSPHOLIPID TRANSACYLATION AND THE FORMATION OF LYSO-PAF, THE PRECURSOR OF PLATELET-ACTIVATING-FACTOR (PAF), The FASEB journal, 9(3), 1995, pp. 115-115
PLATELET-ACTIVATING-FACTOR - THE BIOSYNTHETIC AND CATABOLIC ENZYMES (VOL 305, PG 689, 1995)
Authors: SNYDER F
Citation: F. Snyder, PLATELET-ACTIVATING-FACTOR - THE BIOSYNTHETIC AND CATABOLIC ENZYMES (VOL 305, PG 689, 1995), Biochemical journal, 308, 1995, pp. 1039-1039
PLATELET-ACTIVATING-FACTOR - THE BIOSYNTHETIC AND CATABOLIC ENZYMES
Authors: SNYDER F
Citation: F. Snyder, PLATELET-ACTIVATING-FACTOR - THE BIOSYNTHETIC AND CATABOLIC ENZYMES, Biochemical journal, 305, 1995, pp. 689-705
NEEDLE-USING PRACTICES WITHIN THE SEX INDUSTRY
Authors: KAIL BL WATSON DD RAY S ANDERSEN M BAXTER R BAXTER S BESCHNER G BIERNACKI P BROADNAX S BROWN V DENEAL L DEREN S ESTRADA A FLEMING D FRIEDMAN S GATES S GLIDER P HAMMETT T HUNT D KOTRANSKI L MCCOY C MONDANARO J MUSIKOFF H NEEDLE R RHODES F ROBLES R ROSS R ROUNSAVILLE B SCHENSUL J SHORTY V SIEGAL H SINGER M SNYDER F SOWDER B STEPHENS R STEVENS S VOGTSBERGER K WALTON J WIEBEL W WILLIAMS M WOOD R
Citation: Bl. Kail et al., NEEDLE-USING PRACTICES WITHIN THE SEX INDUSTRY, The American journal of drug and alcohol abuse, 21(2), 1995, pp. 241-255
MOLECULAR-SPECIES OF SPHINGOMYELIN IN SPHINGOMYELINASE-SENSITIVE AND SPHINGOMYELINASE-RESISTANT POOLS OF HL-60 CELLS
Authors: FITZGERALD V BLANK ML SNYDER F
Citation: V. Fitzgerald et al., MOLECULAR-SPECIES OF SPHINGOMYELIN IN SPHINGOMYELINASE-SENSITIVE AND SPHINGOMYELINASE-RESISTANT POOLS OF HL-60 CELLS, Lipids, 30(9), 1995, pp. 805-809
GENERATION OF THE PRECURSOR (LYSO-PAF) OF PLATELET-ACTIVATING-FACTOR VIA A COA-DEPENDENT TRANSACYLASE
Authors: BLANK ML FITZGERALD V SMITH ZL SNYDER F
Citation: Ml. Blank et al., GENERATION OF THE PRECURSOR (LYSO-PAF) OF PLATELET-ACTIVATING-FACTOR VIA A COA-DEPENDENT TRANSACYLASE, Biochemical and biophysical research communications, 210(3), 1995, pp. 1052-1058
PLATELET-ACTIVATING-FACTOR AND ITS ANALOGS - METABOLIC PATHWAYS AND RELATED INTRACELLULAR PROCESSES (VOL 1254, PG 231, 1995)
Authors: SNYDER F
Citation: F. Snyder, PLATELET-ACTIVATING-FACTOR AND ITS ANALOGS - METABOLIC PATHWAYS AND RELATED INTRACELLULAR PROCESSES (VOL 1254, PG 231, 1995), Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1259(1), 1995, pp. 121-121
PLATELET-ACTIVATING-FACTOR AND ITS ANALOGS - METABOLIC PATHWAYS AND RELATED INTRACELLULAR PROCESSES
Authors: SNYDER F
Citation: F. Snyder, PLATELET-ACTIVATING-FACTOR AND ITS ANALOGS - METABOLIC PATHWAYS AND RELATED INTRACELLULAR PROCESSES, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1254(3), 1995, pp. 231-249
THE COA-INDEPENDENT TRANSACYLASE IN PAF BIOSYNTHESIS - TISSUE DISTRIBUTION AND MOLECULAR-SPECIES SELECTIVITY
Authors: BLANK ML SMITH ZL FITZGERALD V SNYDER F
Citation: Ml. Blank et al., THE COA-INDEPENDENT TRANSACYLASE IN PAF BIOSYNTHESIS - TISSUE DISTRIBUTION AND MOLECULAR-SPECIES SELECTIVITY, Biochimica et biophysica acta, L. Lipids and lipid metabolism, 1254(3), 1995, pp. 295-301
DIFFERENTIATION-INDUCED INCREASE OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN HL-60 CELLS
Authors: LEE TC FITZGERALD V CHATTERJEE R MALONE B SNYDER F
Citation: Tc. Lee et al., DIFFERENTIATION-INDUCED INCREASE OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN HL-60 CELLS, Journal of lipid mediators and cell signalling, 9(3), 1994, pp. 267-283
TOPOGRAPHY OF PLATELET-ACTIVATING-FACTOR METABOLISM IN VARIOUS CELL MODELS
Authors: RECORD M RIBBES G LUMB R NINIO E VALLARI D SNYDER F CHAP H
Citation: M. Record et al., TOPOGRAPHY OF PLATELET-ACTIVATING-FACTOR METABOLISM IN VARIOUS CELL MODELS, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 3-5
INVOLVEMENT OF A COA-INDEPENDENT TRANSACYLASE AND UNIQUE TRANSACETYLASE IN THE METABOLISM OF PAF AND RELATED ACETYLATED LIPIDS
Authors: SNYDER F LEE TC UEMURA Y
Citation: F. Snyder et al., INVOLVEMENT OF A COA-INDEPENDENT TRANSACYLASE AND UNIQUE TRANSACETYLASE IN THE METABOLISM OF PAF AND RELATED ACETYLATED LIPIDS, Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 25-31
SUBCELLULAR AND TISSUE DISTRIBUTION OF PLATELET-ACTIVATING-FACTOR (PAF) TRANSACETYLASE
Authors: OU MC LEE TC SNYDER F
Citation: Mc. Ou et al., SUBCELLULAR AND TISSUE DISTRIBUTION OF PLATELET-ACTIVATING-FACTOR (PAF) TRANSACETYLASE, The FASEB journal, 8(7), 1994, pp. 10001402-10001402
METABOLIC PROCESSING OF PAF
Authors: SNYDER F
Citation: F. Snyder, METABOLIC PROCESSING OF PAF, Clinical reviews in allergy, 12(4), 1994, pp. 309-327
INVOLVEMENT OF TRANSACYLASE AND TRANSACETYLASE IN REGULATING THE BIOSYNTHESIS OF ACETYLATED LIPIDS
Authors: SNYDER F LEE TC UEMURA Y OU MC
Citation: F. Snyder et al., INVOLVEMENT OF TRANSACYLASE AND TRANSACETYLASE IN REGULATING THE BIOSYNTHESIS OF ACETYLATED LIPIDS, Journal of cellular biochemistry, 1994, pp. 23-23
INVOLVEMENT OF TRANSACYLASE AND TRANSACETYLASE IN REGULATING THE BIOSYNTHESIS OF ACETYLATED LIPIDS
Authors: SNYDER F LEE TC UEMURA Y OU MC
Citation: F. Snyder et al., INVOLVEMENT OF TRANSACYLASE AND TRANSACETYLASE IN REGULATING THE BIOSYNTHESIS OF ACETYLATED LIPIDS, Journal of cellular biochemistry, 1994, pp. 70-70
THE PACIFIC RIM GOOD LABORATORY PRACTICE INITIATIVES
Authors: SNYDER F
Citation: F. Snyder, THE PACIFIC RIM GOOD LABORATORY PRACTICE INITIATIVES, Journal of the American College of Toxicology, 13(1), 1994, pp. 86-91
Risultati: 1-25 | 26-31